IRCT201102165844N1已完成2 期
effects of acarbose in metabolic control of patients with diabetes mellitus
Deputy for Reaserch of Qazvin University of Medical Science0 个研究点目标入组 45 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 30 years（—）
- 性别
- All
入选标准
- •inclusion criteria :type 1 diabetes, at least from 1years before & HbA1C =7.5% ,exclusion criteria: Cr = 2 , partial GI obstruction,IBD .
排除标准
- 未提供
研究者
相似试验
已完成
4 期
Study for the effect of blood glucose and metabolic risk factors by switching Sulfonylurea to SGLT2 inhibitor in patients with type 2 diabetes. -prospective observational studyType 2 diabetes mellitusJPRN-UMIN000016347Hokkaido University Hospital200
招募中
不适用
‘The effect of L-arabinose on the glycaemic and insulinemic responses after consumption of a liquid product’Eating behaviour, Obesity, Diabetes Mellitus, Metabolic healthNL-OMON22940Wageningen University (WUR)24
已完成
2 期
acrabose effect on weight loseingoverweight.Obesity, unspecifiedIRCT201011151774N3Kerman medical university66
已完成
不适用
Effects for glucose metabolism, body composition, and circulatory dynamics of SGLT2 inhibitorType 2 diabetes mellitusJPRN-UMIN000017195Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki30
尚未招募
4 期
Effects of acarbose and acarbose combined with metformin on the microorganisms in the intestinal tract of Indian patients with type 2 diabetes.CTRI/2022/10/046514Bayer AG